Onconic Therapeutics Inc.

This study is testing a new drug combination for people with advanced stomach cancer that has returned or spread after at least two prior treatments. Researchers want to find a safe dose and see if the combination of JPI-547 and irinotecan can shrink tumors. The trial will enroll…

This study is testing a new drug combination (JPI-547 with bevacizumab) for ovarian cancer that has come back after previous treatments. It aims to see if this combination can help control the cancer longer and is safe for patients. The study is for people whose cancer responded …

This study is testing whether a new drug called JP-1366 can safely reduce heartburn and acid reflux symptoms in people with non-erosive GERD, a condition where they experience symptoms but no visible damage in their esophagus. Researchers will measure how many days participants g…